---
document_datetime: 2023-09-21 20:40:30
document_pages: 10
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/raloxifene-teva-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: raloxifene-teva-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 5.3024766
conversion_datetime: 2025-12-28 05:18:13.76205
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Raloxifene Teva

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                      | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0029               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                           | 08/09/2021                          |                                             | PL                               |           |
| IA/0028              | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an alreadyapproved manufacturer | 12/02/2021                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0027            | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                       | 21/12/2020   |            | Annex II and PL        |                                   |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------------|
| IA/0026            | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                  | 04/11/2020   | n/a        |                        |                                   |
| PSUSA/2603/ 201812 | Periodic Safety Update EU Single assessment - raloxifene                                                                                                                                                                                                                                                                                            | 11/07/2019   | n/a        |                        | PRAC Recommendation - maintenance |
| N/0024             | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                    | 20/11/2018   |            | Labelling and PL       |                                   |
| IAIN/0023          | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                  | 15/06/2017   | n/a        |                        |                                   |
| IAIN/0022          | A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                                                                          | 07/09/2016   | 06/07/2017 | Annex II and PL        |                                   |
| IB/0021/G          | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.a.1.a - Change or addition of imprints,bossing or other markings including replacement,or addition of inks used for product marking - Changes in imprints,bossing or other markings B.II.b.1.a - Replacement or addition of a | 08/08/2016   | 06/07/2017 | SmPC, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| manufacturing site for the site B.II.b.1.a - Replacement manufacturing site for the site B.II.b.1.b - Replacement manufacturing site for the site B.II.b.1.e - Replacement manufacturing site for the manufacturing operation(s) release,batch control,primary packaging,for non-sterile B.II.b.2.a - Change to importer,batch arrangements and quality Replacement/addition of control/testing takes place B.II.b.2.c.1 - Change to arrangements and quality Replacement or addition responsible for importation Not including batch control/testing B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.4.a - Change in the size ranges) of the finished compared to the originallyapproved B.II.b.5.c - Change to in-process applied during the manufacture product - Deletion of a non-significant   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

| applied during the manufacture product - Deletion of a non-significant B.II.b.5.c - Change to in-process applied during the manufacture product - Deletion of a non-significant B.II.b.5.c - Change to in-process applied during the manufacture product - Deletion of a non-significant B.II.b.5.c - Change to in-process applied during the manufacture product - Deletion of a non-significant B.II.b.5.z - Change to in-process applied during the manufacture product - Other variation B.II.b.5.z - Change to in-process applied during the manufacture product - Other variation B.II.b.5.z - Change to in-process applied during the manufacture product - Other variation B.II.c.1.b - Change in the and/or limits of an excipient specification parameter corresponding test method B.II.c.1.c - Change in the and/or limits of an excipient significant specification an obsolete parameter) B.II.c.1.z - Change in the and/or limits of an excipient B.II.c.2.b - Change in test   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | procedure is already authorised B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation B.II.d.2.f - Change in test procedure for the finished product - To reflect compliance with the Ph. Eur. and remove reference to the outdated internal test method and test method number B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of   |            |     |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0020/G | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non-                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 25/07/2016 | n/a |

<div style=\"page-break-after: always\"></div>

|         | parameter) B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.III.1.a.1 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - New certificate from an alreadyapproved manufacturer B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State   |            |            |                        | an obsolete   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|---------------|
| IA/0019 | B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 10/11/2015 | n/a        |                        |               |
| N/0018  | Minor change in labelling or package leaflet not with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 29/07/2015 | 06/07/2017 | Labelling              | connected     |
| T/0017  | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 10/04/2015 | 27/05/2015 | SmPC, Labelling and PL |               |
| IA/0016 | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 19/02/2015 | n/a        |                        | procedure     |

<div style=\"page-break-after: always\"></div>

| IA/0015            | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                                      | 19/02/2015   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0014            | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                                                                        | 10/02/2015   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| R/0013             | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                           | 20/11/2014   | 06/02/2015 | SmPC, Annex II, Labelling and PL | Based on the CHMP review of data on quality, safety and efficacy, including all variations introduced since the marketing authorisation was granted, the CHMP considered that the risk-benefit balance of Raloxifene Teva for the treatment and prevention of osteoporosis in postmenopausal women remains favourable and therefore recommends the renewal of the marketing authorisation. The CHMP recommended that the renewal be granted with unlimited validity. |
| PSUSA/2603/ 201312 | Periodic Safety Update EU Single assessment - raloxifene                                                                                                                                                                                                                                                          | 11/09/2014   | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IA/0012/G          | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites | 01/08/2014   | 06/02/2015 | Annex II and PL                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IB/0011            | B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including                                                                                                                                                                                                             | 26/06/2014   | n/a        |                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

<div style=\"page-break-after: always\"></div>

|           | replacement or addition)                                                                                                                                                                                                                          |            |            |                                  |      |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------|
| N/0009    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                  | 12/03/2014 | 06/02/2015 | PL                               |      |
| IAIN/0008 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                    | 31/05/2013 | n/a        |                                  |      |
| N/0007    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                  | 14/12/2012 | 06/02/2015 | PL                               |      |
| IB/0006   | B.II.c.1.z - Change in the specification parameters and/or limits of an excipient - Other variation                                                                                                                                               | 03/09/2012 | n/a        |                                  |      |
| IB/0005   | B.II.f.1.d - Stability of FP - Change in storage conditions of the finished product or the diluted/reconstituted product                                                                                                                          | 11/05/2012 | 29/10/2012 | SmPC, Annex II, Labelling and PL |      |
| IA/0004   | A.5.b - Administrative change - Change in the name and/or address of a manufacturer of the finished product, including quality control sites (excluding manufacturer for batch release)                                                           | 26/09/2011 | n/a        |                                  |      |
| IA/0003/G | This was an application for a group of variations. B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging | 14/02/2011 | n/a        | Annex II and PL                  | site |

<div style=\"page-break-after: always\"></div>

|           | B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing                                                                                                                                                                                                                                                                                                                                                                                    |            |            |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|
| II/0002/G | This was an application for a group of variations. Alternative manufacturing process. Alternative batch size of the finished product. B.II.b.3.b - Change in the manufacturing process of the finished product - Substantial changes to a manufacturing process that may have a significant impact on the quality, safety and efficacy of the medicinal product B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms | 20/01/2011 | 02/02/2011 |
| IB/0001/G | This was an application for a group of variations. B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place,except batch- release,batch control,primary and secondary packaging,for non-sterile medicinal products B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.1.a - Replacement or addition of a                                                                                | 21/01/2011 | n/a        |

<div style=\"page-break-after: always\"></div>

| site                                                |
|-----------------------------------------------------|
| B.II.b.2.a - Change to batch release arrangements   |
| and quality control testing of the FP - Replacement |
| or addition of a site where batch control/testing   |
| takes place                                         |